BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Adempas (Riociguat) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Adempas (Riociguat)\, from ClinicalTrials
 .gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT05825417-581@assetmemo.bio
DTSTAMP:20261121T005643Z
DTSTART;VALUE=DATE:20280131
DTEND;VALUE=DATE:20280201
SUMMARY:Adempas (Riociguat): Phase 4 readout est. (NCT05825417)
DESCRIPTION:Adempas (Riociguat)\, phase 4\, Pulmonary Arterial Hypertension
 .\nStudy: Pulmonary Hypertension: Intensification and Personalisation of C
 ombination Rx\nEstimated primary completion: January 2028. This is a Clini
 calTrials.gov estimate\, not a confirmed readout date\, and it can move.\n
 Drug page: https://assetmemo.bio/drug/riociguat#upcoming-events\nRegistry 
 record: https://clinicaltrials.gov/study/NCT05825417
URL:https://assetmemo.bio/drug/riociguat#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07644377-581@assetmemo.bio
DTSTAMP:20261121T005643Z
DTSTART;VALUE=DATE:20310131
DTEND;VALUE=DATE:20310201
SUMMARY:Adempas (Riociguat): Phase 3 readout est. (NCT07644377)
DESCRIPTION:Adempas (Riociguat)\, phase 3.\nStudy: Discontinuation Versus C
 ontinuation of Riociguat Monotherapy in Chronic Thromboembolic Pulmonary H
 ypertension Successfully Treated With Balloon Pulmonary Angioplasty\nEstim
 ated primary completion: 31 January 2031. This is a ClinicalTrials.gov est
 imate\, not a confirmed readout date\, and it can move.\nDrug page: https:
 //assetmemo.bio/drug/riociguat#upcoming-events\nRegistry record: https://c
 linicaltrials.gov/study/NCT07644377
URL:https://assetmemo.bio/drug/riociguat#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
